Trial intelligence / Profile preview

Booster Study of DTPw-HBV/Hib and Mencevax ACW in Primed Toddlers

NCT00317109Phase 3Completed

Sponsor
GSK
Start
Apr 2006
Primary completion
May 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Mencevax ACW in meningococcal infection, sponsored by GSK. Started Apr 2006; status: completed.

02

Drugs

Mencevax ACW
03

Conditions

meningococcal infection

Beyond the preview

Go deeper on NCT00317109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00317109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call